Genetic Testing Technology Among Assets Acquired by Labcorp from Invitae
Labcorp has acquired select assets from Invitae to enhance its genetic testing technology and improve its personalized care abilities.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Company News |
Labcorp has acquired select assets from Invitae to enhance its genetic testing technology and improve its personalized care abilities.
Read MorePosted by Andy Lundin | Jul 16, 2024 | Breast |
Many breast cancer survivors who qualify for genetic testing are not receiving it, though those who do often discuss results with family.
Read MorePosted by Andy Lundin | Jun 11, 2024 | Research |
Avalon Healthcare Solutions’ Lab Trend Report found the use of genetic testing increased last year, while routine testing remained stable.
Read MorePosted by Chris Wolski | Feb 26, 2024 | Cancer |
The team will work to improve the genetic testing and clinical management of hereditary and multiple primary cancers in African Americans.
Read MorePosted by Chris Wolski | Dec 5, 2023 | Sequencing Systems |
Genomenon, a genomic intelligence company, has launched Genomenon Curate-Pro, a rapid on-demand...
Read More